Salesforce vs HIVE Blockchain Technologies Which Performs Better?
Salesforce and HIVE Blockchain Technologies are two companies operating in different sectors but both are publicly traded stocks that have garnered attention from investors. Salesforce is a well-established cloud-based software company known for its customer relationship management solutions. On the other hand, HIVE Blockchain Technologies is a cryptocurrency mining company that focuses on blockchain technology. Each company offers unique investment opportunities with potential for growth and profitability in their respective industries. It is important for investors to carefully consider their investment goals and risk tolerance when evaluating these two stocks.
Salesforce or HIVE Blockchain Technologies?
When comparing Salesforce and HIVE Blockchain Technologies, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Salesforce and HIVE Blockchain Technologies.
Dividend Investors:
Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company.
Salesforce has a dividend yield of 0.47%, while HIVE Blockchain Technologies has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Salesforce reports a 5-year dividend growth of 0.00% year and a payout ratio of 13.71%. On the other hand, HIVE Blockchain Technologies reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.
Value Investors:
Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Salesforce P/E ratio at 58.49 and HIVE Blockchain Technologies's P/E ratio at -18.34. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Salesforce P/B ratio is 5.72 while HIVE Blockchain Technologies's P/B ratio is 2.13.
Growth Investors:
Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Salesforce has seen a 5-year revenue growth of 1.16%, while HIVE Blockchain Technologies's is 3.87%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Salesforce's ROE at 9.58% and HIVE Blockchain Technologies's ROE at -15.17%.
Retail Investors:
Retail investors often consider stock affordability and company familiarity. For example, day low prices are $325.25 for Salesforce and $4.92 for HIVE Blockchain Technologies. Over the past year, Salesforce's prices ranged from $211.76 to $344.87, with a yearly change of 62.86%. HIVE Blockchain Technologies's prices fluctuated between $2.18 and $5.74, with a yearly change of 163.30%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.